Disclaimer

The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • 7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • +886-2-77201070
  • info@gravitycapital.com
  • Disclaimer

    The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

    In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • address:
    7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • tel:
    +886-2-77201070
  • email:
    info@gravitycapital.com
  • A Big Congratulations to Beijing San Valley Medical Testing Facility Passing 2017 “National Tumor Cell Mutation High Throughput Sequencing Detection” External Quality Assessment with Full Scores!

    Release time: 2017-05-05Number of visits:606author:admin

    External quality assessment (EQA), is the highest level of quality testing of a laboratory’s testing capabilities and qualities, conducted by the Clinical Testing Center, and Pathology Quality Control Center under National Health and Family Planning Commission (NHFPC), and multiple other authorized agencies annually.

    In 2017, Beijing San Valley medical testing facility (abbreviated as “San Valley Testing”) participated in the first “National Tumor Cell Mutation High Throughput Sequencing Detection” EQA conducted by NHFPC, and passes with a full score again.  

    This is the first occasion where NHFPC lists Tumor Cell Mutation High Throughput Sequencing Detection as a part of the EQA, used to examine any laboratory’s ability to detect, annotate, and interpret cell mutation. 102 laboratories for 18 provinces (City, Autonomous Regions) took part in this assessment, 92 of them report their results within the set time frame. In this round of assessment, the passing rate for Tumor Cell Mutation High Throughput Sequencing Detection is only 52.3%(49/92), while only 45.7% (42/92)of laboratories that passes with full scores.

    San Valley Testing’s repeated success in the “National Tumor Cell Mutation High Throughput Sequencing Detection” EQA conducted by NHFPC demonstrates our excellent capabilities in tumor cell mutation high throughput sequencing detection, and also a rare opportunity to assess and supervise the efficacy and reliability of our quality control.

    Ever since our founding, San Valley Testing eagerly participates in every annual national level EDA and achieve excellent results; in our day-to day testing service we also hold true to our “Accurate, Timely, High-quality, Scientifically Just and Continuous Improvements” quality principles. We are determined to execute our holistic quality control regiments under the guideline of ISO 15189; we guarantee to closely monitor the quality of our service closely at every stage of the process, in order to provide crucial and accurate data for accurate treatment of disease and personalized medical guidance for better diagnostics processes and bring greater benefits for clinical patients!